Travere Therapeutics (TVTX) Tax Rate (2014 - 2026)

Travere Therapeutics (TVTX) has 13 years of Tax Rate data on file, last reported at 0.33% in Q1 2026.

• Quarterly Tax Rate rose 42.0% year-over-year to 0.33% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 1.85% (down 186.0% YoY) and the FY2025 annual result came in at 2.01%, down 197.0% from the prior year.
• Tax Rate rose to 0.33% in Q1 2026, from 4.37% in the prior quarter.
• In the past five years, Tax Rate ranged from a high of 0.33% in Q1 2026 to a low of 4.37% in Q4 2025.
• A 5-year average of 0.29% and a median of 0.07% in 2022 frame the typical range for Tax Rate.
• Annual changes were most pronounced in 2022 — Tax Rate surged 52 bps — and 2025, when it tumbled 449 bps.
• Tracing TVTX's Tax Rate over 5 years: stood at 0.07% in 2022, then slipped by 4 bps to 0.08% in 2023, then soared by 255 bps to 0.12% in 2024, then sank by 3764 bps to 4.37% in 2025, then surged by 107 bps to 0.33% in 2026.
• The last three Tax Rate figures came in at 0.33% (Q1 2026), 4.37% (Q4 2025), and 0.03% (Q3 2025), per Business Quant data.